These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34109623)

  • 1. Dual Functions of Riboflavin-functionalized Poly(lactic-co-glycolic acid) Nanoparticles for Enhanced Drug Delivery Efficiency and Photodynamic Therapy in Triple-negative Breast Cancer Cells.
    Mekseriwattana W; Phungsom A; Sawasdee K; Wongwienkham P; Kuhakarn C; Chaiyen P; Katewongsa KP
    Photochem Photobiol; 2021 Nov; 97(6):1548-1557. PubMed ID: 34109623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
    Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
    Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
    Wang S; Zhang J; Wang Y; Chen M
    Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitors in triple-negative breast cancer cell line.
    Byrne CE; Astete CE; Vaithiyanathan M; Melvin AT; Moradipour M; Rankin SE; Knutson BL; Sabliov CM; Martin EC
    Nanomedicine (Lond); 2020 Apr; 15(10):981-1000. PubMed ID: 32238059
    [No Abstract]   [Full Text] [Related]  

  • 5. Using anti-PD-L1 antibody conjugated gold nanoshelled poly (Lactic-co-glycolic acid) nanocapsules loaded with doxorubicin: A theranostic agent for ultrasound imaging and photothermal/chemo combination therapy of triple negative breast cancer.
    Jiang H; Zhou Y; Zheng D; Cheng Y; Xiang D; Jiang L; Du J
    J Biomed Mater Res A; 2024 Mar; 112(3):402-420. PubMed ID: 37941485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer.
    Dinakar YH; Rajana N; Kumari NU; Jain V; Mehra NK
    AAPS PharmSciTech; 2023 Dec; 24(8):258. PubMed ID: 38097825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual drug loaded PLGA nanospheres for synergistic efficacy in breast cancer therapy.
    Deepika MS; Thangam R; Sheena TS; Vimala RTV; Sivasubramanian S; Jeganathan K; Thirumurugan R
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109716. PubMed ID: 31349431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
    Voon SH; Tiew SX; Kue CS; Lee HB; Kiew LV; Misran M; Kamkaew A; Burgess K; Chung LY
    J Biomed Nanotechnol; 2016 Jul; 12(7):1431-52. PubMed ID: 29336539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy.
    Devulapally R; Lee T; Barghava-Shah A; Sekar TV; Foygel K; Bachawal SV; Willmann JK; Paulmurugan R
    Nanomedicine (Lond); 2018 May; 13(9):1051-1066. PubMed ID: 29790803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
    Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICG/l-Arginine Encapsulated PLGA Nanoparticle-Thermosensitive Hydrogel Hybrid Delivery System for Cascade Cancer Photodynamic-NO Therapy with Promoted Collagen Depletion in Tumor Tissues.
    Sun Z; Wang X; Liu J; Wang Z; Wang W; Kong D; Leng X
    Mol Pharm; 2021 Mar; 18(3):928-939. PubMed ID: 33427470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancer.
    Chaudhari D; Kuche K; Yadav V; Ghadi R; Date T; Bhargavi N; Jain S
    Drug Deliv Transl Res; 2023 Apr; 13(4):1074-1087. PubMed ID: 36528709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy.
    Bhargava-Shah A; Foygel K; Devulapally R; Paulmurugan R
    Nanomedicine (Lond); 2016 Feb; 11(3):235-47. PubMed ID: 26787319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifting the absorption to the near-infrared region and inducing a strong photothermal effect by encapsulating zinc(II) phthalocyanine in poly(lactic-co-glycolic acid)-hyaluronic acid nanoparticles.
    Gao D; Wong RCH; Wang Y; Guo X; Yang Z; Lo PC
    Acta Biomater; 2020 Oct; 116():329-343. PubMed ID: 32890751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation of Carnosic-Acid-Loaded Polymeric Nanoparticles: An Attempt to Endorse the Bioavailability and Anticancer Efficacy of Carnosic Acid against Triple-Negative Breast Cancer.
    Chatterjee S; Chakraborty P; Dutta S; Karak S; Mahalanobis S; Ghosh N; Dewanjee S; Sil PC
    ACS Appl Bio Mater; 2024 Mar; 7(3):1656-1670. PubMed ID: 38364267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells.
    Cerqueira BBS; Lasham A; Shelling AN; Al-Kassas R
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():593-600. PubMed ID: 28482569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.